Table 2. Analysis of changes in CK2 gene expression in CNS cancer.

P-values, fold change, rank and datasets are shown.

Gene	p-value	Fold Change	Rank (Top %)	Dataset	#Samples	Reference
Astrocytoma
CK2α	0.001	1.352	8%	Shai Brain	42	[53]
	0.003	-1.322	9%	Sun Brain	180	[58]
CK2β	3.12 10−4	1.518	5%	Shai Brain	42	[53]
Glioblastoma (Astrocytoma Grade IV)
CK2α	2.02 10−6	1.370	15%	Sun Brain	180	[58]
	2.33 10−4	1.294	11%	Shai Brain	42	[53]
	9.21 10−4	4.072	13%	Bredel Brain 2	54	[59]
	0.01	-2.382	42%	Lee Brain	101	[52]
CK2α’	2.59 10−4	-2.132	23%	Lee Brain	101	[52]
	8.13 10−4	-1.314	17%	Bredel Brain 2	54	[59]
CK2β	1.52 10−7	1.440	2%	Shai Brain	42	[53]
	1.19 10−5	-2.338	14%	Lee Brain	101	[52]
Anaplastic Oligodendroglioma (grade III)
CK2α’	1.15 10−6	1.637	3%	French Brain	33	[60]
CK2β	0.001	1.499	15%	French Brain	33	[60]
Anaplastic Oligoastrocytoma (oligodendroglioma + astrocytoma)
CK2α	0.008	1.686	12%	French Brain	33	[60]
CK2α’	0.004	-1.624	14%	Bredel Brain 2	54	[59]
CK2β	0.003	1.569	8%	French Brain	33	[60]